Current Understanding on the Role of Standard and Immunoproteasomes in Inflammatory/Immunological Pathways of Multiple Sclerosis

Current Understanding on the Role of Standard and Immunoproteasomes in Inflammatory/Immunological Pathways of Multiple Sclerosis

The ubiquitin-proteasome system is the major intracellular molecular machinery for protein degradation and maintenance of protein homeostasis in most human cells. As ubiquitin-proteasome system plays a critical role in the regulation of the immune system, it might also influence the development and...

Full description

Bibliographic Details
Main Authors:	Elena Bellavista, Aurelia Santoro, Daniela Galimberti, Cristoforo Comi, Fabio Luciani, Michele Mishto
Format:	Article
Language:	English
Published:	Hindawi Limited 2014-01-01
Series:	Autoimmune Diseases
Online Access:	http://dx.doi.org/10.1155/2014/739705

Similar Items

Immunoproteasome LMP2 60HH variant alters MBP epitope generation and reduces the risk to develop multiple sclerosis in Italian female population.
by: Michele Mishto, et al.
Published: (2010-02-01)

Denervation-Induced Activation of the Standard Proteasome and Immunoproteasome.
by: Haiming M Liu, et al.
Published: (2016-01-01)

Untangling Extracellular Proteasome-Osteopontin Circuit Dynamics in Multiple Sclerosis
by: Chiara Dianzani, et al.
Published: (2019-03-01)

Immunoproteasome deficiency modifies the alternative pathway of NFκB signaling.
by: Marcela Maldonado, et al.
Published: (2013-01-01)

Immunoproteasome Function in Normal and Malignant Hematopoiesis
by: Nuria Tubío-Santamaría, et al.
Published: (2021-06-01)

Corneal wound healing is compromised by immunoproteasome deficiency.
by: Deborah A Ferrington, et al.
Published: (2013-01-01)

TAM Receptor Pathways at the Crossroads of Neuroinflammation and Neurodegeneration
by: Giacomo Tondo, et al.
Published: (2019-01-01)

Immunoproteasome functions explained by divergence in cleavage specificity and regulation
by: Michael B Winter, et al.
Published: (2017-11-01)

Computational analysis and modeling of cleavage by the immunoproteasome and the constitutive proteasome
by: Lafuente Esther M, et al.
Published: (2010-09-01)

The Immunoproteasome and Viral Infection: A Complex Regulator of Inflammation
by: Mary Katherine McCarthy, et al.
Published: (2015-01-01)

New Insights into the Function of the Immunoproteasome in Immune and Nonimmune Cells
by: Hiroaki Kimura, et al.
Published: (2015-01-01)

Advances in Understanding the Immunological Pathways in Psoriasis
by: Simona-Roxana Georgescu, et al.
Published: (2019-02-01)

mTORC1 accelerates retinal development via the immunoproteasome
by: Ji-Heon Choi, et al.
Published: (2018-06-01)

Investigating AKT activation and autophagy in immunoproteasome-deficient retinal cells.
by: Md Razaul Karim, et al.
Published: (2020-01-01)

Immunoproteasome deficiency protects in the retina after optic nerve crush.
by: Nathan J Schuld, et al.
Published: (2015-01-01)

Quantitative time-resolved analysis reveals intricate, differential regulation of standard- and immuno-proteasomes
by: Juliane Liepe, et al.
Published: (2015-09-01)

Mechanistic and thermodynamic characterization of oxathiazolones as potent and selective covalent immunoproteasome inhibitors
by: Levente M. Mihalovits, et al.
Published: (2021-01-01)

Immunoproteasome expression is associated with better prognosis and response to checkpoint therapies in melanoma
by: Shelly Kalaora, et al.
Published: (2020-02-01)

Discovery of Immunoproteasome Inhibitors Using Large-Scale Covalent Virtual Screening
by: Andrea Scarpino, et al.
Published: (2019-07-01)

Immunoproteasome and Non-Covalent Inhibition: Exploration by Advanced Molecular Dynamics and Docking Methods
by: Giulia Culletta, et al.
Published: (2021-07-01)

The immunoproteasome‐specific inhibitor ONX 0914 reverses susceptibility to acute viral myocarditis
by: Nadine Althof, et al.
Published: (2018-02-01)

The immunoproteasome subunit LMP10 mediates angiotensin II-induced retinopathy in mice
by: Shuai Wang, et al.
Published: (2018-06-01)

Immunoproteasome Inhibition Impairs T and B Cell Activation by Restraining ERK Signaling and Proteostasis
by: Christian Schmidt, et al.
Published: (2018-10-01)

A dominant role for the immunoproteasome in CD8+ T cell responses to murine cytomegalovirus.
by: Sarah Hutchinson, et al.
Published: (2011-02-01)

Immunoproteasomes Control the Homeostasis of Medullary Thymic Epithelial Cells by Alleviating Proteotoxic Stress
by: Charles St-Pierre, et al.
Published: (2017-11-01)

L’immunoprotéasome : régulateur de transcription et promoteur de survie cellulaire
by: Rouette, Alexandre
Published: (2017)

A Nut for Every Bolt: Subunit-Selective Inhibitors of the Immunoproteasome and Their Therapeutic Potential
by: Eva M. Huber, et al.
Published: (2021-07-01)

The Immunoproteasome Subunits LMP2, LMP7 and MECL-1 Are Crucial Along the Induction of Cerebral Toxoplasmosis
by: Timothy French, et al.
Published: (2021-04-01)

HLA-dependent heterogeneity and macrophage immunoproteasome activation during lung COVID-19 disease
by: Christophe Desterke, et al.
Published: (2021-07-01)

Structure of human immunoproteasome with a reversible and noncompetitive inhibitor that selectively inhibits activated lymphocytes
by: Ruda de Luna Almeida Santos, et al.
Published: (2017-11-01)

Co-Inhibition of the Immunoproteasome Subunits LMP2 and LMP7 Ameliorates Immune Thrombocytopenia
by: Sheng-hong Du, et al.
Published: (2021-01-01)

Immunoproteasome overexpression underlies the pathogenesis of thyroid oncocytes and primary hypothyroidism: studies in humans and mice.
by: Hiroaki J Kimura, et al.
Published: (2009-11-01)

Development of a novel immunoproteasome digestion assay for synthetic long peptide vaccine design.
by: Hiroshi Wada, et al.
Published: (2018-01-01)

Omega-3 PUFAs Suppress IL-1β-Induced Hyperactivity of Immunoproteasomes in Astrocytes
by: Emilia Zgorzynska, et al.
Published: (2021-05-01)

Multiple sclerosis: current immunological aspects
by: Carlos Cuevas-García
Published: (2017-02-01)

Treatment of Chronic Inflammatory Demyelinating Polyneuropathy: From Molecular Bases to Practical Considerations
by: Paolo Ripellino, et al.
Published: (2014-01-01)

Understanding the Roles of the Kynurenine Pathway in Multiple Sclerosis Progression
by: Chai K. Lim, et al.
Published: (2010-08-01)

Understanding the Roles of the Kynurenine Pathway in Multiple Sclerosis Progression
by: Chai K. Lim, et al.
Published: (2010-01-01)

Immunological Mechanisms and Natalizumab Treatment in Multiple Sclerosis : Studies on lymphocytes, inflammatory markers and magnetic resonance spectroscopy
by: Mellergård, Johan
Published: (2012)

Antiphospholipid Syndrome and the Neurologist: From Pathogenesis to Therapy
by: Thomas Fleetwood, et al.
Published: (2018-11-01)